Balthaser Kevin — SEC Form 4 filings
SEC reporting owner CIK 1957554. 11 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-05 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 55.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | Chief Financial Officer | 11 | — | — | 55 |
Form 4 filings — Balthaser Kevin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-03 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 2,375 · Tax withholding (F): 677 @ $2.87 · Option exercise (M): 2,375 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Grant/award (A): 99,100 (derivative) @ $0 · Grant/award (A): 346,800 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 22,025 · Tax withholding (F): 6,449 @ $3.47 · Option exercise (M): 22,025 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 14,750 · Tax withholding (F): 4,984 @ $3.51 · Option exercise (M): 14,750 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 73,750 · Tax withholding (F): 19,934 @ $3.01 · Option exercise (M): 7,500 · Tax withholding (F): 2,250 @ $3.01 · Option exercise (M): 13,200 · Tax withholding (F): 4,461 @ $2.88 · +3 more | EDGAR |
| 2025-03-04 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 1,100 · Option exercise (M): 2,375 · Tax withholding (F): 727 @ $1.99 · Option exercise (M): 1,100 (derivative) @ $0 · Option exercise (M): 2,375 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 14,750 · Tax withholding (F): 5,816 @ $2.48 · Option exercise (M): 14,750 (derivative) @ $0 · Grant/award (A): 88,100 (derivative) @ $0 · Grant/award (A): 308,200 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 73,750 · Tax withholding (F): 30,732 @ $2.48 · Option exercise (M): 7,500 · Tax withholding (F): 2,430 @ $2.48 · Option exercise (M): 13,200 · Tax withholding (F): 5,059 @ $2.48 · +4 more | EDGAR |
| 2024-09-04 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 1,000 · Tax withholding (F): 286 @ $1.18 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 1,100 · Tax withholding (F): 313 @ $1.24 · Option exercise (M): 2,375 · Tax withholding (F): 677 @ $1.24 · Option exercise (M): 1,500 · Tax withholding (F): 427 @ $1.24 · +3 more | EDGAR |
| 2024-02-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Grant/award (A): 206,500 (derivative) @ $0 · Grant/award (A): 59,000 (derivative) @ $0 · Grant/award (A): 147,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1957554 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →